Profile data is unavailable for this security.
About the company
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
- Revenue in USD (TTM)11.04bn
- Net income in USD988.00m
- Incorporated1996
- Employees46.00k
- LocationQuest Diagnostics Inc500 Plaza DriveSECAUCUS 07094United StatesUSA
- Phone+1 (302) 658-7581
- Fax+1 (302) 655-5049
- Websitehttps://www.questdiagnostics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ensign Group Inc | 5.06bn | 343.97m | 12.39bn | 46.00k | 36.48 | 5.55 | 27.61 | 2.45 | 5.84 | 5.84 | 85.94 | 38.42 | 0.9984 | -- | 8.38 | 109,953.10 | 6.80 | 6.66 | 8.11 | 8.05 | 21.07 | 21.89 | 6.81 | 6.82 | -- | -- | 0.0597 | 5.16 | 18.72 | 16.05 | 15.44 | 15.07 | 20.77 | 4.77 |
| Universal Health Services Inc | 17.36bn | 1.49bn | 12.51bn | 88.10k | 8.85 | 1.72 | 5.88 | 0.7206 | 23.15 | 23.15 | 269.38 | 119.15 | 1.16 | -- | 7.27 | 197,103.60 | 10.08 | 7.25 | 12.43 | 8.67 | -- | -- | 8.70 | 6.85 | 0.9803 | 12.43 | 0.3908 | 5.70 | 9.71 | 8.48 | 30.36 | 9.61 | 6.69 | 31.95 |
| Tenet Healthcare Corp | 21.31bn | 1.41bn | 21.12bn | 77.00k | 15.68 | 5.00 | 6.54 | 0.9912 | 15.49 | 15.49 | 234.60 | 48.53 | 0.7271 | 10.89 | 7.78 | 276,753.30 | 8.08 | 7.28 | 11.63 | 10.40 | 82.26 | 82.59 | 11.11 | 10.10 | 1.68 | 6.79 | 0.5948 | 0.00 | 3.07 | 3.85 | -56.03 | 28.67 | 13.34 | -- |
| Centene Corp | 194.78bn | -6.67bn | 21.55bn | 61.10k | -- | 1.08 | -- | 0.1106 | -13.62 | -13.62 | 394.60 | 40.57 | 2.45 | -- | 10.30 | 3,187,840.00 | -8.39 | 0.4693 | -15.17 | 0.7727 | 7.12 | 10.08 | -3.43 | 0.237 | -- | -0.3658 | 0.4646 | 0.00 | 19.44 | 11.88 | -301.94 | -- | -2.47 | -- |
| Humana Inc | 129.66bn | 1.19bn | 21.90bn | 67.06k | 18.51 | 1.24 | 10.29 | 0.1689 | 9.81 | 9.81 | 1,074.55 | 146.42 | 2.72 | -- | -- | 1,933,552.00 | 2.74 | 4.86 | -- | -- | -- | -- | 1.01 | 2.05 | -- | 5.40 | 0.4109 | 19.22 | 10.11 | 10.94 | -1.57 | -18.81 | -10.75 | 3.02 |
| Quest Diagnostics Inc | 11.04bn | 988.00m | 22.89bn | 46.00k | 23.73 | 3.20 | 14.54 | 2.07 | 8.78 | 8.78 | 97.65 | 65.18 | 0.6816 | 39.06 | 8.14 | 239,891.30 | 6.20 | 8.03 | 7.25 | 9.31 | 33.29 | 34.91 | 9.10 | 11.33 | 0.9609 | 6.55 | 0.4377 | 28.58 | 11.78 | 3.18 | 14.09 | -7.06 | 4.74 | 7.68 |
| Labcorp Holdings Inc | 13.95bn | 876.50m | 23.32bn | 71.00k | 27.06 | 2.70 | 14.96 | 1.67 | 10.46 | 10.46 | 166.54 | 104.86 | 0.7588 | 19.34 | 6.40 | 196,502.80 | 4.77 | 5.49 | 5.74 | 6.56 | 28.76 | 30.73 | 6.29 | 8.12 | 1.23 | 5.69 | 0.3956 | -- | 7.25 | -0.0384 | 17.49 | -10.85 | 2.63 | -- |
| Natera Inc | 2.31bn | -208.16m | 29.34bn | 6.14k | -- | 16.89 | -- | 12.72 | -1.53 | -1.53 | 16.87 | 12.26 | 1.14 | 14.36 | 7.55 | 375,894.20 | -10.26 | -25.04 | -12.72 | -31.42 | 64.75 | 56.35 | -9.03 | -28.37 | 3.24 | -- | 0.0448 | -- | 35.90 | 42.61 | -9.31 | -- | 48.00 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 13.26m | 11.92% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 6.17m | 5.55% |
| T. Rowe Price Associates, Inc. (IM)as of 31 Dec 2025 | 6.13m | 5.51% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 5.38m | 4.84% |
| Boston Partners Global Investors, Inc.as of 31 Dec 2025 | 3.91m | 3.52% |
| JPMorgan Investment Management, Inc.as of 31 Dec 2025 | 3.74m | 3.36% |
| Geode Capital Management LLCas of 31 Dec 2025 | 3.03m | 2.72% |
| Victory Capital Management, Inc. (Investment Management)as of 31 Dec 2025 | 2.13m | 1.91% |
| Grantham, Mayo, Van Otterloo & Co. LLCas of 31 Dec 2025 | 1.82m | 1.63% |
| Edgepoint Investment Group, Inc.as of 31 Dec 2025 | 1.66m | 1.49% |
